Findings across pre-clinical models in the development of PT-112, a novel investigational platinum-pyrophosphate anti-cancer agent

导出原文传递

翻译打印收藏纠错

作者： Ames, T. ^[1] ; Slusher, B. ^[2] ; Wozniak, K. ^[3] ; Takase, Y. ^[4] ; Shimizu, H. ^[5] ; Nishibata-Kobayashi, K. ^[6] ; Kanada-Sonobe, R. M. ; Kerns, W. ; Fong, K. L. ; Pourquier, P. ; Gongora, C. ; Jimeno, J. ; Chatterjee, D.

作者单位： Johns Hopkins Univ, Sch Med, Johns Hopkins Drug Discovery, Baltimore, MD USA ^[1] Rhode Isl Hosp, Providence, RI USA ^[2] Accellient Partners, Toxicol & Pharmacokinet, Waltham, MA USA ^[3] Inst Rech Cancerol Montpellier, Cellular Biol, Montpellier, France ^[4] Eisai & Co Ltd, Discovery Chem, Tsukuba, Ibaraki, Japan ^[5] Phosplatin Therapeut, Clin & Translat Res & Dev, New York, NY USA ^[6]

发布时间 2018-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

European journal of cancer

2016年68卷

S153-S153页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Findings across pre-clinical models in the development of PT-112, a novel investigational platinum-pyrophosphate anti-cancer agent

European journal of cancer

相似文献

European journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Findings across pre-clinical models in the development of PT-112, a novel investigational platinum-pyrophosphate anti-cancer agent

European journal of cancer

相似文献

European journal of cancer

相关期刊

检索历史清除